You have 9 free searches left this month | for more free features.

Overall Status

Completed (17)

Recruiting (6)

Not yet recruiting (3)

Phase

phase 3 (15)

phase 2 (5)

phase 4 (5)

phase 1 (1)

Sponsor

Forest Laboratories (16)

AbbVie (4)

Aalborg University Hospital (1)

Dr. Martin A. Katzman (1)

Gedeon Richter Plc. (1)

New York State Psychiatric Institute (1)

Sultan Qaboos University (1)

The Medical Research Network (1)

Collaborator

Gedeon Richter Ltd. (13)

AbbVie (1)

Mental Health Center North Zealand (1)

Mental Health Center, Glostrup (1)

Mental Health Department Odense, University Clinic (1)

Psychiatric Center Copenhagen, Rigshospitalet (1)

Intervention

cariprazine (26)

placebo (17)

antidepressant therapy (adt) (1)

aripiprazole (1)

lithium (1)

risperidone (1)

risperidone/moxifloxacin (1)

treatment as usual (1)

Study Documents

Intervention Type

drug (26)

combination product (1)

Funder Type

Industry (21)

Other (5)

Study Type

Interventional (26)

cariprazine

Showing 26 - 26 of 26

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Schizophrenia Trial in United States (Cariprazine, Risperidone/Moxifloxacin)

Completed

Schizophrenia

Cariprazine
Risperidone/Moxifloxacin

Glendale, California
+3 more

Feb 7, 2012